Literature DB >> 12186167

Incidence of neural tube defects in Ontario, 1986-1999.

Enza Gucciardi1, Mary-Anne Pietrusiak, Donna L Reynolds, Jocelyn Rouleau.   

Abstract

BACKGROUND: Prenatal screening and the promotion of folic acid intake could affect the incidence of neural tube defects (NTDs). We examined trends in the total NTD incidence, as detected in live births, stillbirths and therapeutic abortions, from 1986 to 1999 in Ontario.
METHODS: To capture cases of NTDs we used data from the Canadian Congenital Anomalies Surveillance System and hospital data on therapeutic abortions. We calculated the total incidence of NTDs by combining the numbers of NTDs occurring in live births, stillbirths and therapeutic abortions.
RESULTS: The total NTD incidence rate increased from 11.7 per 10,000 pregnancies in 1986 to 16.2 per 10,000 in 1995, and it subsequently decreased to 8.6 per 10,000 by 1999. The NTD birth rate (live births and stillbirths) decreased from 10.6 per 10,000 births in 1986 to 5.3 per 10,000 in 1999. The rate of therapeutic abortions with an NTD or hydrocephalus rose from 17.5 per 10,000 abortions in 1986 to 50.7 per 10,000 in 1995 and fell to 28.7 per 10,000 abortions in 1999.
INTERPRETATION: The total NTD incidence rate increased from 1986 to 1995, probably because of increased prenatal screening and better detection of NTDs. The decline from 1995 to 1999 may have been due to increased folic acid intake among women at the time of conception.

Entities:  

Mesh:

Year:  2002        PMID: 12186167      PMCID: PMC117467     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  16 in total

1.  Quantifying the decline in the birth prevalence of neural tube defects in England and Wales.

Authors:  J K Morris; N J Wald
Journal:  J Med Screen       Date:  1999       Impact factor: 2.136

2.  Measuring up: a health surveillance update on canadian children and youth.

Authors:  D F Smith
Journal:  Paediatr Child Health       Date:  1999-11       Impact factor: 2.253

3.  Folic acid and neural tube defects. Good news at last!

Authors:  G Koren
Journal:  Can Fam Physician       Date:  1999-11       Impact factor: 3.275

4.  Impact of prenatal diagnosis on the birth prevalence of neural tube defects, Atlanta, 1990-1991.

Authors:  H E Roberts; C A Moore; J D Cragan; P M Fernhoff; M J Khoury
Journal:  Pediatrics       Date:  1995-11       Impact factor: 7.124

5.  Neural tube defects along the Texas-Mexico border, 1993-1995.

Authors:  K A Hendricks; J S Simpson; R D Larsen
Journal:  Am J Epidemiol       Date:  1999-06-15       Impact factor: 4.897

6.  Temporal trends in Canadian birth defects birth prevalences, 1979-1993.

Authors:  K C Johnson; J Rouleau
Journal:  Can J Public Health       Date:  1997 May-Jun

7.  The impact of prenatal diagnosis on NTD surveillance.

Authors:  W P Allen; R E Stevenson; S J Thompson; J H Dean
Journal:  Prenat Diagn       Date:  1996-06       Impact factor: 3.050

8.  Recommendations on the use of folic acid supplementation to prevent the recurrence of neural tube defects. Clinical Teratology Committee, Canadian College of Medical Geneticists.

Authors:  M I Van Allen; F C Fraser; L Dallaire; J Allanson; D R McLeod; E Andermann; J M Friedman
Journal:  CMAJ       Date:  1993-11-01       Impact factor: 8.262

9.  Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation.

Authors:  A E Czeizel; I Dudás
Journal:  N Engl J Med       Date:  1992-12-24       Impact factor: 91.245

10.  Prevalence of neural tube defects in northeastern France, 1979-1992 impact of prenatal diagnosis.

Authors:  Y Alembik; B Dott; M P Roth; C Stoll
Journal:  Ann Genet       Date:  1995
View more
  22 in total

1.  Neural tube defects and periconceptional folic acid.

Authors:  Rezan A Kadir; Demetrios L Economides
Journal:  CMAJ       Date:  2002-08-06       Impact factor: 8.262

2.  Reevaluating the benefits of folic acid fortification in the United States: economic analysis, regulation, and public health.

Authors:  Scott D Grosse; Norman J Waitzman; Patrick S Romano; Joseph Mulinare
Journal:  Am J Public Health       Date:  2005-09-29       Impact factor: 9.308

3.  The impact of prenatal diagnosis on neural tube defect (NTD) pregnancy versus birth incidence in British Columbia.

Authors:  Margot I Van Allen; Erin Boyle; Paul Thiessen; Deborah McFadden; Douglas Cochrane; G Keith Chambers; Sylvie Langlois; Patricia Stathers; Beverly Irwin; Elizabeth Cairns; Patrick MacLeod; Marie-France Delisle; Soo-Hong Uh
Journal:  J Appl Genet       Date:  2006       Impact factor: 3.240

Review 4.  The changing incidence of myelomeningocele and its impact on pediatric neurosurgery: a review from the Children's Memorial Hospital.

Authors:  Robin M Bowman; Vanda Boshnjaku; David G McLone
Journal:  Childs Nerv Syst       Date:  2009-03-27       Impact factor: 1.475

5.  [Not Available].

Authors: 
Journal:  Paediatr Child Health       Date:  2005-07       Impact factor: 2.253

6.  Use of anencephalic newborns as organ donors.

Authors: 
Journal:  Paediatr Child Health       Date:  2005-07       Impact factor: 2.253

7.  Folate bioavailability: implications for establishing dietary recommendations and optimizing status.

Authors:  Marie A Caudill
Journal:  Am J Clin Nutr       Date:  2010-03-10       Impact factor: 7.045

8.  Plasma folate status and dietary folate intake among Chinese women of childbearing age.

Authors:  Yaling Zhao; Ling Hao; Le Zhang; Yihua Tian; Yiwu Cao; Haihui Xia; Yajun Deng; Tiangui Wang; Ming Yu; Zhu Li
Journal:  Matern Child Nutr       Date:  2009-04       Impact factor: 3.092

9.  Folate during reproduction: the Canadian experience with folic acid fortification.

Authors:  Gillian Lindzon; Deborah L O'Connor
Journal:  Nutr Res Pract       Date:  2007-09-30       Impact factor: 1.926

10.  Changes in frequencies of select congenital anomalies since the onset of folic acid fortification in a Canadian birth defect registry.

Authors:  Kimberly A Godwin; Barbara Sibbald; Tanya Bedard; Boris Kuzeljevic; R Brian Lowry; Laura Arbour
Journal:  Can J Public Health       Date:  2008 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.